extract: 2015-00-00-cooper-star-trek-communicator-cell-phone-myth-disconfirmation

Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>

domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md

@@ -85,10 +85,16 @@ BALANCE Model's dual payment mechanism (capitation adjustment + reinsurance) plu
 
 
 ### Additional Evidence (challenge)
-*Source: [[2025-12-01-who-glp1-guidelines-behavioral-therapy-combination]] | Added: 2026-03-18*
+*Source: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination | Added: 2026-03-18*
 
 WHO's conditional recommendation structure and behavioral therapy requirement suggest the 'chronic use model' framing may be incomplete. The guideline establishes medication-plus-behavioral-therapy as the standard, not medication alone, which may have different economics than the pure pharmaceutical model. WHO also announced it will develop 'an evidence-based prioritization framework to identify which adults with obesity should be prioritized for GLP-1 treatment'—implying targeted use rather than universal chronic treatment.
 
+
+### Additional Evidence (challenge)
+*Source: [[2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach]] | Added: 2026-03-18*
+
+If GLP-1 + exercise produces durable weight maintenance (3.5 kg regain vs 8.7 kg for medication alone), then the chronic use assumption may be wrong. Patients who establish exercise habits during a 1-2 year medication window may not need indefinite treatment, fundamentally changing the cost trajectory. The inflationary projection assumes continuous medication; the combination data suggests a time-limited intervention model may be viable.
+
 ---
 
 Relevant Notes:

domains/health/glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md

@@ -73,10 +73,16 @@ BALANCE Model's manufacturer-funded lifestyle support requirement directly addre
 
 
 ### Additional Evidence (extend)
-*Source: [[2025-12-01-who-glp1-guidelines-behavioral-therapy-combination]] | Added: 2026-03-18*
+*Source: 2025-12-01-who-glp1-guidelines-behavioral-therapy-combination | Added: 2026-03-18*
 
 WHO's conditional recommendation requiring behavioral therapy combination provides international regulatory support for adherence interventions. The guideline explicitly states GLP-1s should be 'combined with intensive behavioral therapy to maximize and sustain benefits'—directly addressing the persistence problem by making behavioral support the standard of care rather than an optional add-on.
 
+
+### Additional Evidence (extend)
+*Source: [[2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach]] | Added: 2026-03-18*
+
+Weight regain data shows that even among patients who complete treatment, GLP-1 alone produces 8.7 kg regain (vs 7.6 kg placebo) while GLP-1 + exercise produces only 3.5 kg regain. This means low persistence may be economically rational for patients if the medication alone doesn't create lasting value—the 15% two-year persistence rate may reflect patients discovering that medication without lifestyle change produces temporary results.
+
 ---
 
 Relevant Notes:

inbox/queue/.extraction-debug/2018-00-00-lithub-diamond-musk-misreads-foundation-trilogy.json

@@ -0,0 +1,24 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "fiction-to-reality-pipeline-transmits-philosophical-architecture-not-guaranteed-wisdom.md",
+      "issues": [
+        "no_frontmatter"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 1,
+    "kept": 0,
+    "fixed": 1,
+    "rejected": 1,
+    "fixes_applied": [
+      "fiction-to-reality-pipeline-transmits-philosophical-architecture-not-guaranteed-wisdom.md:set_created:2026-03-18"
+    ],
+    "rejections": [
+      "fiction-to-reality-pipeline-transmits-philosophical-architecture-not-guaranteed-wisdom.md:no_frontmatter"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-18"
+}

inbox/queue/.extraction-debug/2025-01-00-chaffer-agentbound-tokens-ai-accountability.json

@@ -0,0 +1,37 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 2,
+    "kept": 0,
+    "fixed": 7,
+    "rejected": 2,
+    "fixes_applied": [
+      "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:set_created:2026-03-18",
+      "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:stripped_wiki_link:coding agents cannot take accountability for mistakes",
+      "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:stripped_wiki_link:coding-agents-cannot-take-accountability-for-mistakes-which-",
+      "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:stripped_wiki_link:AI-agents-as-personal-advocates-collapse-Coasean-transaction",
+      "accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:set_created:2026-03-18",
+      "accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:stripped_wiki_link:economic-forces-push-humans-out-of-every-cognitive-loop-wher",
+      "accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:stripped_wiki_link:adaptive-governance-outperforms-rigid-alignment-blueprints-b"
+    ],
+    "rejections": [
+      "cryptoeconomic-staking-creates-ai-agent-accountability-through-automatic-slashing-without-human-discretion.md:missing_attribution_extractor",
+      "accountability-scales-with-autonomy-as-design-principle-for-ai-agent-governance.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-18"
+}

inbox/queue/.extraction-debug/2025-01-01-aha-food-is-medicine-systematic-review-rcts.json

@@ -0,0 +1,25 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 1,
+    "kept": 0,
+    "fixed": 2,
+    "rejected": 1,
+    "fixes_applied": [
+      "food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md:set_created:2026-03-18",
+      "food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md:stripped_wiki_link:SDOH-interventions-show-strong-ROI-but-adoption-stalls-becau"
+    ],
+    "rejections": [
+      "food-is-medicine-rcts-show-consistent-diet-quality-improvements-but-inconsistent-clinical-outcomes.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-18"
+}

inbox/queue/.extraction-debug/2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach.json

@@ -0,0 +1,25 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 1,
+    "kept": 0,
+    "fixed": 2,
+    "rejected": 1,
+    "fixes_applied": [
+      "glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md:set_created:2026-03-18",
+      "glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md:stripped_wiki_link:glp-1-persistence-drops-to-15-percent-at-two-years-for-non-d"
+    ],
+    "rejections": [
+      "glp-1-combined-with-structured-exercise-achieves-60-percent-better-weight-maintenance-than-medication-alone-after-discontinuation.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-18"
+}

inbox/queue/2018-00-00-lithub-diamond-musk-misreads-foundation-trilogy.md

@@ -7,9 +7,13 @@ date: 2018-00-00
 domain: entertainment
 secondary_domains: [grand-strategy]
 format: article
-status: unprocessed
+status: null-result
 priority: medium
 tags: [fiction-to-reality-pipeline, foundation-asimov, spacex, musk, critical-analysis, survivorship-bias, narrative-infrastructure]
+processed_by: clay
+processed_date: 2026-03-18
+extraction_model: "anthropic/claude-sonnet-4.5"
+extraction_notes: "LLM returned 1 claims, 1 rejected by validator"
 ---
 
 ## Content
@@ -50,3 +54,10 @@ Literary critic Jonny Diamond argues that Elon Musk fundamentally misapplies Asi
 PRIMARY CONNECTION: the fiction-to-reality pipeline is real but probabilistic
 WHY ARCHIVED: Critical counter-perspective that accepts the pipeline's causal direction while questioning the quality of outcome. Adds important nuance: pipeline transmits influence, not wisdom.
 EXTRACTION HINT: Could yield a refinement or challenge to the pipeline claim — "pipeline shapes strategic mission but doesn't guarantee the mission is well-formed." Consider as evidence for the "probabilistic" qualifier in Belief 2.
+
+
+## Key Facts
+- Elon Musk cited Asimov's Foundation trilogy as influence for SpaceX in 2017 Rolling Stone interview
+- Musk stated his goal as 'take the set of actions that are likely to prolong civilization' and minimize dark ages
+- Jonny Diamond is Literary Hub's editor in chief
+- Article published circa 2018 after the 2017 Rolling Stone profile

inbox/queue/2025-01-00-chaffer-agentbound-tokens-ai-accountability.md

@@ -7,10 +7,14 @@ date: 2025-01-01
 domain: ai-alignment
 secondary_domains: [internet-finance]
 format: article
-status: unprocessed
+status: null-result
 priority: medium
 tags: [agentbound-tokens, accountability, skin-in-the-game, cryptoeconomics, mechanism-design, AI-agents, governance]
 flagged_for_rio: ["Cryptoeconomic mechanism design for AI agent accountability — tiered staking, slashing, DAO governance. Rio should evaluate whether the staking mechanism has prediction market properties for surfacing AI reliability signals"]
+processed_by: theseus
+processed_date: 2026-03-18
+extraction_model: "anthropic/claude-sonnet-4.5"
+extraction_notes: "LLM returned 2 claims, 2 rejected by validator"
 ---
 
 ## Content
@@ -63,3 +67,12 @@ PRIMARY CONNECTION: [[coding agents cannot take accountability for mistakes whic
 WHY ARCHIVED: First governance mechanism specifically designed for AI agent accountability using cryptoeconomic principles. Also relevant to Rio's mechanism design territory.
 
 EXTRACTION HINT: Focus on the accountability-scales-with-autonomy principle and the staking model structure. Note the key limitation: measurement dependency. Do not over-claim — this is a working paper with no deployment evidence.
+
+
+## Key Facts
+- Agentbound Tokens (ABTs) are cryptographic tokens serving as 'tamper-proof digital birth certificates' for autonomous AI agents
+- ABT mechanism includes temporary blacklisting for repeat offenses
+- ABT validator DAOs use hybrid human-AI oversight
+- ABT governance uses utility-weighted voting where power derives from task success rates and energy efficiency
+- ABT governance includes per-agent caps to prevent monopolization
+- Working paper authored by Tomer Jordi Chaffer at McGill University with contributions from Goldston, Muttoni, Zhao, Shaw Walters

inbox/queue/2025-01-01-aha-food-is-medicine-systematic-review-rcts.md

@@ -7,9 +7,13 @@ date: 2025-01-01
 domain: health
 secondary_domains: []
 format: systematic-review
-status: unprocessed
+status: null-result
 priority: high
 tags: [food-is-medicine, systematic-review, rct, hba1c, blood-pressure, bmi, aha, clinical-outcomes, evidence-review]
+processed_by: vida
+processed_date: 2026-03-18
+extraction_model: "anthropic/claude-sonnet-4.5"
+extraction_notes: "LLM returned 1 claims, 1 rejected by validator"
 ---
 
 ## Content
@@ -63,3 +67,13 @@ AHA Scientific Statement published in Circulation reviewing 14 US randomized con
 PRIMARY CONNECTION: Existing food-as-medicine / SDOH evidence claims in health domain
 WHY ARCHIVED: Most authoritative US RCT evidence review on FIM clinical outcomes — the canonical source for "what the evidence actually says"
 EXTRACTION HINT: Extract two claims: (1) FIM consistently improves diet quality and food security (proven); (2) FIM clinical outcomes (HbA1c, BP, BMI) are inconsistent and often non-significant in RCTs (likely). These are different claims that the field conflates.
+
+
+## Key Facts
+- AHA Scientific Statement reviewed 14 US randomized controlled trials of Food Is Medicine interventions
+- FIM intervention types reviewed: medically tailored meals, produce prescriptions, medically tailored groceries, food pharmacies
+- Clinical outcomes assessed: HbA1c, blood pressure, BMI
+- Medically tailored meals have the most evidence and highest intervention specificity among FIM types
+- AHA supports expansion and standardization of FIM programs despite inconsistent RCT evidence
+- Recipe4Health observational study (2,643 participants) showed HbA1c -0.37%, non-HDL -17 mg/dL but was not an RCT
+- Multisite evaluation of 9 produce prescription programs showed improvements in food security and F&V intake but was not RCT design

inbox/queue/2026-03-01-glp1-lifestyle-modification-efficacy-combined-approach.md

@@ -7,9 +7,13 @@ date: 2026-03-01
 domain: health
 secondary_domains: []
 format: review
-status: unprocessed
+status: enrichment
 priority: high
 tags: [glp-1, lifestyle-modification, exercise, sarcopenia, muscle-preservation, adherence, weight-regain, obesity]
+processed_by: vida
+processed_date: 2026-03-18
+enrichments_applied: ["glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -75,3 +79,12 @@ Synthesis of 2025-2026 research on combining lifestyle modifications (diet, exer
 PRIMARY CONNECTION: GLP-1 cost-effectiveness under capitation requires solving the adherence paradox (March 12 claim candidate)
 WHY ARCHIVED: The "exercise is the active ingredient for weight maintenance" finding significantly changes how to evaluate BALANCE model design and GLP-1 economic models under VBC
 EXTRACTION HINT: Focus on the GLP-1 alone vs. GLP-1+exercise regain comparison — this is the claim-worthy finding. Also note the BALANCE model design needs evaluation against this evidence.
+
+
+## Key Facts
+- WHO December 2025 guidelines recommend GLP-1 therapies 'combined with intensive behavioral therapy to maximize and sustain benefits'
+- Meta-analysis of 22 RCTs with 2,258 participants found ~25% of GLP-1 weight loss is lean mass
+- Without exercise, 15-40% of GLP-1 weight loss is lean mass; with resistance training, lean mass loss is substantially reduced
+- Up to 50% of adults over 80 experience sarcopenia; aging reduces muscle mass 12-16% independent of weight loss interventions
+- Tirzepatide may have better muscle preservation profile than semaglutide (preliminary data, not FDA-approved for this indication)
+- BALANCE model includes lifestyle support component but specific exercise programming details not specified in source